Fernando M. Rodrigues sold $98k of TDOC
President of BetterHelp at Teladoc Health, Inc.. 15,251 shares at an average of $6.44, traded Sep 2, 2026, filed Sep 3, 2026.
Score components
- +20RolePresident
- +10Trade size$98k at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002037547-26-000008, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | MOption exercise Common Stock10b5-1 | +5,492 | - | - | 5,492 | 39 d ago |
| Sep 1, 2026 | MOption exercise Common Stock10b5-1 | +1,042 | - | - | 6,534 | 39 d ago |
| Sep 1, 2026 | MOption exercise Common Stock10b5-1 | +8,717 | - | - | 15,251 | 39 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stock10b5-1 | -5,439 | $6.30 | $34k | 9,812 | 39 d ago |
| Sep 3, 2026 | SOpen-market sale Common Stock10b5-1 | -9,812 | $6.51 | $64k | 0 | 39 d ago |
| Sep 1, 2026 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -5,492 | $0.00 | $0 | 5,492 | 39 d ago |
| Sep 1, 2026 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -1,042 | $0.00 | $0 | 2,084 | 39 d ago |
| Sep 1, 2026 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -8,717 | $0.00 | $0 | 52,302 | 39 d ago |
Related signals
Other insiders at Teladoc Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | TDOCsell Teladoc Health, Inc. | Joseph Ronald Catapano Chief Accounting Officer | $3,703 655 shares | -4% | |
| 35Weak | Teladoc Health, Inc. | Charles Divita III CHIEF EXECUTIVE OFFICER | $109k 17,805 shares | -4% | |
| 26Weak | Teladoc Health, Inc. | Kelly Bliss President, U.S. Group Health | $46k 7,357 shares | -7% | |
| 15Weak | Teladoc Health, Inc. | Joseph Ronald Catapano Chief Accounting Officer | $1,726 274 shares | -2% | |
| 35Weak | Teladoc Health, Inc. | Charles Divita III CHIEF EXECUTIVE OFFICER | $115k 18,327 shares | -4% | |
| 26Weak | Teladoc Health, Inc. | Carlos Nueno President, International | $39k 6,200 shares | -9% | |
| 22Weak | Teladoc Health, Inc. | Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY | $48k 7,573 shares | -6% | |
| 11Weak | TDOCsell Teladoc Health, Inc. | Kelly Bliss President, U.S. Group Health | $34k 4,582 shares | -7% | |
| 10Weak | TDOCsell Teladoc Health, Inc. | Joseph Ronald Catapano Chief Accounting Officer | $23k 2,972 shares | -36% | |
| 36Weak | Teladoc Health, Inc. | Charles Divita III CHIEF EXECUTIVE OFFICER | $127k 16,787 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.